Паранеопластический миозит. Особенности дебюта, клинической картины, течения, стероид-респонсивности

1. <div><p>Насонов Е.Л. Воспалительные заболевания мышц. В кн.: Рациональная фармакотерапия ревматических заболеваний. М.: Литтерра, 2003; 195—202.</p><p>Mahil S., Marks D., McCormack M., Rahman A. Dermatomyositis. Br J Hosp Med (Lond) 2012;73:18-22.</p><p>Дворецкий Л.И. Паранеопластические синдромы. М.: Media Medica, 2000.</p><p>Wortmann R.L. Diseases of Skeletal Muscle. Philadelphia: Lippincott, Williams and Wilkins, 1998; 45—57.</p><p>Chen Y.J., Wu C.Y., Huang Y.L. et al. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthrs Res Ther 2010;12:70.</p><p>So M.W., Koo B.S., Kim Y.G. et al. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis. J Rheumatol 2011;38:2432-5.</p><p>Dalakas M.C., Hohlfeld R. Pofymyositis and dermatomyositis. Lancet 2003;362:971-82.</p><p>Насонов Е.Л., Штутман В.З., Саложин К.В. и др. Клиникоиммунологическая гетерогенность идиопатических воспалительных миопатий. Клин мед 1995;2:3-8.</p><p>Ohashi M., Shu E., Tokuzumi M. et al. Anti-p155/140 antibody-positive dermatomyositis with metastasis originating from an unknown site. Acta Derm Venereol 2011;91:84-5.</p><p>Shimizu J. Malignancy-associated myositis. Brain Nerve 2010;62:427—32.</p><p>Selva-O’Callaghan A., Trallero-Araguаs E., Grau-Junyent J.M., Labrador-Horrillo M. Malignancy and myositis: novel autoantibodies and new insights. Curr Opin Rheumatol 2010;22:627-32.</p><p>Zahr Z.A., Baer A.N. Malignancy in myositis. Curr Rheumatol Rep 2011;13:208-15.</p><p>Trallero-Araguаs E., Labrador-Horrillo M., Selva-O’Callaghan A. et al. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) 2010;89:47-52.</p><p>Ikeda N., Takahashi K., Yamaguchi Y. et al. Analysis of dermato-myositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol 2011;38:973-9.</p><p>Ichimura Y., Matsushita T., Hamaguchi Y. et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 2012;71:710—3.</p><p>Xu T., Hong S. A case of vesiculobullous dermatomyositis: a marker of internal malignancy. Int J Dermatol 2012 51:594—6.</p><p>Caratta P.R., Mafort T., Pamplona M. et al. Paraneoplastic vesiculobullous dermatomyositis with synchronic prostate and tongue tumors: case report. Rev Bras Reumatol 2011;51:394-6, 407.</p><p>Girouard S.D., Velez N.F., Penson R.T. et al. Panniculitis associated with dermatomyositis and recurrent ovarian cancer. Arch Dermatol 2012; Mar 19 [Epub. ahead of print].</p><p>Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403.</p><p>Bohan A., Peter J.B., Bowman R.L., Pearson C.M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56:255.</p><p>Антелава О.А., Насонов Е.Л. Современные методы оценки активности и повреждения при идиопатических воспалительных миопатиях. Науч-практич ревматол 2007;1:59—62.</p></div><br />